RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
Clinical trial NCT03815682 · TERMINATED
Trial details
- NCT number
- NCT03815682
- Sponsor
- Repertoire Immune Medicines
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2022-09-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.